HF006
The percentage of patients with a current diagnosis of heart failure due to left ventricular systolic dysfunction, who are currently treated with a beta-blocker licensed for heart failure
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF004 | 2019 | 59 | 63 | 93.7% | |
| HF004 | 2020 | 138 | 148 | 93.2% | |
| HF006 | 2021 | 162 | 180 | 90.0% | |
| HF006 | 2022 | 187 | 204 | 91.7% | |
| HF006 | 2023 | 264 | 276 | 95.7% |
